Biopharmaceuticals Market

SKU: DMBT253 | Last Updated On: Jan 21 2022 | No. of Pages: 180 | Available Formats

> Global Biopharmaceuticals Market Expected to reach a high CAGR of 14.20% By 2028: DataM Intelligence

Global Biopharmaceuticals Market is segmented By Type (Monoclonal Antibody, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines, Recombinant Enzymes), By Application (Oncology, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Disease Prevention, Cardiovascular Diseases, Neurological Diseases), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2021-2028

 

Market- Overview

The Global "Biopharmaceuticals Market" is expected to reach at a CAGR of 14.20% during the forecast period (2021-2028).  

Biopharmaceuticals are large and complex molecular drugs that are mainly obtained from proteins and nucleic acids of living organisms such as microorganisms and animal cells also known as transgenic organisms. These drugs are obtained using biotechnology and have high-therapeutic value. Biopharmaceuticals are also known as biologics and biotech drugs and are usually administered by intravenous, subcutaneous, or intramuscular injections and are more efficient than the conventional small molecule drugs.

 

Source: DataM Intelligence Analysis (2021)

Market Dynamics

The growth of the global biopharmaceuticals market is driven by the increase in the elderly population, surge in prevalence of chronic diseases such as cancer and diabetes, increase in obesity and sedentary lifestyle among the population and growing acceptance for biopharmaceuticals due to their ability to treat previously untreatable diseases.

Increasing acceptance and huge market demand for biopharmaceuticals will drive the market growth  

The efficacy and safety of biopharmaceutical products, combined with their ability to address previously untreatable conditions, allows pharma companies to command high prices for innovative drugs. Strong demand has driven significant profits, despite the high cost of goods sold. Investing in biotech R&D has yielded better returns than the pharma-industry average. The current biologics-development pipeline supports an outlook of continued healthy growth. There are currently more than 1,500 biomolecules undergoing clinical trials, and the success rate for biologics has so far been over twice that of small-molecule products, with 13 percent of biopharma products that enter the Phase I trial stage going on to launch. The success of the clinical pipeline will lead to an unprecedented number of new molecule launches, rising from a handful a few years ago to 10 to 15 annually, as biopharma products make up an increasing share of new approvals from the US Food and Drug Administration in the future. A further steep increase is to be expected as multiple players begin to receive approval for the production of biosimilars after 2015.

Biopharmaceuticals looks poised to transform the industry once more, as increasing understanding of the interaction between drugs and the genetic makeup of patients helps to improve the targeting of therapies. Combined with robust, low-cost genetic profiling, this knowledge will improve treatment outcomes and serve to accelerate and improve the outcomes of clinical trials, helping to reduce the cost of drug development.

High costs associated and strict regulatory framework is likely to hamper the market growth

However, high costs associated with drug development and their threat of failure, challenging development process, and strict regulatory framework are going to restrain the market in the forecast period.

Generally, the development of a biopharmaceutical product takes around 5 to 9 years and costs over $ 100 million. The regulatory framework plays a major role in deriving incentives for investment and establishing sufficient quality and safety for biomedical products. The WHO has set strict approval standards for biopharmaceuticals. These factors will hamper the market growth in the forecast period.

COVID-19 Impact Analysis

The ongoing COVID-19 pandemic globally is expected to have a significant impact on the biopharmaceutical market. Most of the biopharmaceutical companies are striving extensively for the development of vaccines against the SARS-CoV2 virus. Some of the candidates are traditional-type vaccines such as inactivated and attenuated products; however, most of the vaccine candidates being developed are advanced DNA, RNA, and protein subunit vaccines. This factor is expected to boost the growth of the biopharmaceuticals market over the pandemic. However, the clinical and regulatory procedures for drug candidates of other indications may witness a slow pace due to the shifting priorities of the healthcare system to reduce the infections to clinical trial patients.

Segment Analysis

Monoclonal antibody segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)  

Monoclonal antibodies is the emerging technology that is identical to immune cells and represents a copy of the unique parent cell. The successful use of monoclonal antibodies and antibody derivatives in therapeutics is the major driver for the rapid growth of the studied segment. The therapeutic applications of monoclonal antibodies include in the areas of cancer, rheumatoid arthritis, multiple sclerosis, and cardiovascular diseases, among others. The growing FDA approvals and new product launches for various indications are expected to drive the segment. For instance, in October 2019, Novartis received the FDA approval for its Beovu (brolucizumab) injection, also known as RTH258, for the treatment of wet age-related macular degeneration (AMD). In March 2019, the US FDA approved Pfizer’s oncology biosimilar, TRAZIMERA, which is a monoclonal antibody biosimilar to the originator biologic medicine, Herceptin. Thus, owing to the aforementioned factors, the monoclonal antibodies segment is anticipated to witness significant growth over the forecast period.

Source: DataM Intelligence Analysis (2021)

Geographical Analysis

North America region holds the largest market share of global biopharmaceuticals market

North America accounts for the largest share in the global biopharmaceuticals market in 2020 and is expected to remain dominant over the forecast period. The growing burden of chronic disease and increasing investments in research and development activities in the United States are the major factors driving the biopharmaceuticals market in North America. The United States has been recognized as the innovation capital of the world for life sciences, and it is involved in global capital investments in the early stages of biopharmaceutical companies.

According to Globocan 2020, the estimated incidence of cancer cases in the United States accounted for 2,281,658, with 612,390 deaths, in 2020. The high incidence of cancer surges the demand for effective therapeutics, and thus, drives the studied market. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), in 2018, more than 4.7 million people worked in the US biopharmaceutical industry across a broad spectrum of occupations, including scientific research, technical support, and manufacturing. Additionally, in March 2020, Thermo Fisher Scientific Inc. invested nearly USD 475 million as a biopharma investment in the expansion of biologics, cell and gene therapy, and drug product development and to increase its commercial capabilities globally. Similarly, in January 2020, Eli Lilly and Company entered an agreement to acquire Dermira, a biopharmaceutical company. This acquisition aids in the expansion of the company's biopharmaceutical portfolio with the addition of Dermira's lebrikizumab, an IL-13 antibody that is intended for use in the treatment of moderate-to-severe atopic dermatitis. Thus, given factors, is expected to drive the market in North America.

Source: DataM Intelligence Analysis (2021)

Competitive Landscape

The biopharmaceuticals market is moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Abbvie Inc., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Novartis AG, Novo Nordisk AS, Pfizer Inc., GlaxoSmithKline PLC, and F. Hoffmann-La Roche AG among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Biopharmaceuticals Market globally. For instance, in July 2021, Takeda Pharmaceutical and Frazier Healthcare Partners have partnered to launch a biopharmaceutical company named HilleVax to develop and market Takeda’s norovirus vaccine candidate, HIL-214.  

Amgen Inc.

Overview:

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures, and markets medicines for grievous illnesses.

Product Portfolio:

BEHIND MVASI: MVASI® is approved to treat metastatic colorectal cancer (mCRC) for First- or second-line treatment in combination with intravenous fluorouracil-based chemotherapy.

Why Purchase the Report?

  • Visualize the composition of the global biopharmaceuticals market segmentation by type, application and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in global biopharmaceuticals market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global biopharmaceuticals Market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global biopharmaceuticals market report would provide an access to an approximately 40+ market data table, 45+ figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Biopharmaceuticals Market– By Type

  • Monoclonal Antibody
  • Recombinant Growth Factors
  • Purified Proteins
  • Recombinant Proteins
  • Recombinant Hormones
  • Synthetic Immunomodulators
  • Vaccines
  • Recombinant Enzymes

Global Biopharmaceuticals Market- By Application

  • Oncology
  • Autoimmune Disorders
  • Metabolic Disorders
  • Hormonal Disorders
  • Disease Prevention
  • Cardiovascular Diseases
  • Neurological Diseases

Global Biopharmaceuticals Market- By Region

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

Trending Topics

Biopharmaceuticals Market

Radiopharmaceuticals Market

Table of Contents

Table of Contents

  1. Global Biopharmaceuticals Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Biopharmaceuticals Market– Market Definition and Overview

  3. Global Biopharmaceuticals Market– Executive Summary

    1. Market snippet By Type
    2. Market Snippet By Application
    3. Market Snippet by Region
  4. Global Biopharmaceuticals Market– Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. Increasing Acceptance and Huge Market Demand for Biopharmaceuticals
        2. Ability of Biopharmaceuticals to Treat Previously Untreatable Diseases
      2. Restraints:
        1. High-end Manufacturing Requirements
      3. Opportunity
      4. Impact Analysis
  5. Global Biopharmaceuticals Market– Industry Analysis

    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Regulatory Analysis
  6. Global Biopharmaceuticals Market– COVID-19 Analysis

    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. Global Biopharmaceuticals Market– By Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      2. Market Attractiveness Index, By Type
    2. Monoclonal Antibody *
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Recombinant Growth Factors
    4. Purified Proteins
    5. Recombinant Proteins
    6. Recombinant Hormones
    7. Synthetic Immunomodulators
    8. Vaccines
    9. Recombinant Enzymes
  8. Global Biopharmaceuticals Market– By Application

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      2. Market Attractiveness Index, By Application Segment
    2. Oncology *
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Autoimmune Disorders
    4.  Metabolic Disorders
    5. Hormonal Disorders
    6. Disease Prevention
    7. Cardiovascular Diseases
    8.  Neurological Diseases
  9. Global Biopharmaceuticals Market– By Region

    1. Introduction
      1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  10. Global Biopharmaceuticals Market– Competitive Landscape

    1. Key Developments and Strategies
    2. Company Share Analysis
    3. Product Benchmarking
    4. Key Companies to Watch
  11. Global Biopharmaceuticals Market- Company Profiles

    1. Abbvie Inc *
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Amgen Inc.
    3. Bristol-Myers Squibb Company
    4.  Eli Lilly and Company
    5.  Johnson & Johnson
    6.  Novartis AG
    7.  Novo Nordisk AS
    8.  Pfizer Inc.
    9.  GlaxoSmithKline PLC
    10.  F. Hoffmann-La Roche AG (*LIST NOT EXHAUSTIVE)
  12. Global Biopharmaceuticals Market– DataM

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables & Figures

 List of Tables

Table 01 Global Biopharmaceuticals Market Value, By Type, 2020, 2024 & 2028 ($ Million)

Table 02 Global Biopharmaceuticals Market Value, By Application, 2020, 2024 & 2028 ($ Million)

Table 03 Global Biopharmaceuticals Market Value, By Region, 2020, 2024 & 2028 ($ Million)

Table 04 Global Biopharmaceuticals Market Value, By Type, 2020, 2024 & 2028 ($ Million)

Table 05 Global Biopharmaceuticals Market Value, By Type, 2019-2028 ($ Million)

Table 06 Global Biopharmaceuticals Market Value, By Application, 2020, 2024 & 2028 ($ Million)

Table 07 Global Biopharmaceuticals Market Value, By Application, 2019-2028 ($ Million)

Table 08 Global Biopharmaceuticals Market Value, By Region, 2020, 2024 & 2028 ($ Million)

Table 09 Global Biopharmaceuticals Market Value, By Region, 2019-2028 ($ Million)

Table 10 North America Biopharmaceuticals Market Value, By Type, 2019-2028 ($ Million)

Table 11 North America Biopharmaceuticals Market Value, By Application, 2019-2028 ($ Million)

Table 12 North America Biopharmaceuticals Market Value, By Country, 2019-2028 ($ Million)

Table 13 South America Biopharmaceuticals Market Value, By Type, 2019-2028 ($ Million)

Table 14 South America Biopharmaceuticals Market Value, By Application, 2019-2028 ($ Million)

Table 15 South America Biopharmaceuticals Market Value, By Country, 2019-2028 ($ Million)

Table 16 Europe Biopharmaceuticals Market Value, By Type, 2019-2028 ($ Million)

Table 17 Europe Biopharmaceuticals Market Value, By Application, 2019-2028 ($ Million)

Table 18 Europe Biopharmaceuticals Market Value, By Country, 2019-2028 ($ Million)

Table 19 Asia-Pacific Biopharmaceuticals Market Value, By Type, 2019-2028 ($ Million)

Table 20 Asia-Pacific Biopharmaceuticals Market Value, By Application, 2019-2028 ($ Million)

Table 21 Asia-Pacific Biopharmaceuticals Market Value, By Country, 2019-2028 ($ Million)

Table 22 Middle East & Africa Biopharmaceuticals Market Value, By Type, 2019-2028 ($ Million)

Table 23 Middle East & Africa Biopharmaceuticals Market Value, By Application, 2019-2028 ($ Million)

Table 24 Abbvie Inc.: Overview

Table 25 Abbvie Inc.: Product Portfolio

Table 26 Abbvie Inc.: Key Developments

Table 27 Amgen Inc.: Overview

Table 28 Amgen Inc.: Product Portfolio

Table 29 Amgen Inc.: Key Developments

Table 30 Bristol-Myers Squibb Company: Overview

Table 31 Bristol-Myers Squibb Company: Product Portfolio

Table 32 Bristol-Myers Squibb Company: Key Developments

Table 33 Eli Lilly and Company: Overview

Table 34 Eli Lilly and Company: Product Portfolio

Table 35 Eli Lilly and Company: Key Developments

Table 36 Johnson & Johnson: Overview

Table 37 Johnson & Johnson: Product Portfolio

Table 38 Johnson & Johnson: Key Developments

Table 39 Novartis AG: Overview

Table 40 Novartis AG: Product Portfolio

Table 41 Novartis AG: Key Developments

Table 42 Novo Nordisk AS: Overview

Table 43 Novo Nordisk AS: Product Portfolio

Table 44 Novo Nordisk AS: Key Developments

Table 45 Pfizer Inc.: Overview

Table 46 Pfizer Inc.: Product Portfolio

Table 47 Pfizer Inc.: Key Developments

Table 48 GlaxoSmithKline PLC: Overview

Table 49 GlaxoSmithKline PLC: Product Portfolio

Table 50 GlaxoSmithKline PLC: Key Developments

Table 51 F. Hoffmann-La Roche AG: Overview

Table 52 F. Hoffmann-La Roche AG: Product Portfolio

Table 53 F. Hoffmann-La Roche AG: Key Developments

List of Figures

Figure 01 Global Biopharmaceuticals Market Share, By Type, 2020 & 2028 (%)

Figure 02 Global Biopharmaceuticals Market Share, By Application, 2020 & 2028 (%)

Figure 03 Global Biopharmaceuticals Market Share, By Region, 2020 & 2028 (%)

Figure 04 Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 05 Global Biopharmaceuticals Market Y-o-Y Growth, By Type, 2020-2028 (%)

Figure 06 Monoclonal Antibody: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 07 Recombinant Growth Factors: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 08 Purified Proteins: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 09 Recombinant Proteins: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 10 Recombinant Hormones: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 11 Synthetic Immunomodulators: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 12 Vaccines: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 13 Recombinant Enzymes: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 14 Global Biopharmaceuticals Market Y-o-Y Growth, By Application, 2020-2028 (%)

Figure 15 Oncology: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 16 Autoimmune Disorders: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 17 Metabolic Disorders: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 18 Hormonal Disorders: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 19 Disease Prevention: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 20 Cardiovascular Diseases: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 21 Neurological Diseases: Global Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 22 Global Biopharmaceuticals Market Y-o-Y Growth, By Region, 2020-2028 (%)

Figure 23 North America Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 24 North America Biopharmaceuticals Market Share, By Type, 2020 & 2028 (%)

Figure 25 North America Biopharmaceuticals Market Share, By Application, 2020 & 2028 (%)

Figure 26 North America Biopharmaceuticals Market Share, By Country, 2020 & 2028 (%)

Figure 27 South America Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 28 South America Biopharmaceuticals Market Share, By Type, 2020 & 2028 (%)

Figure 29 South America Biopharmaceuticals Market Share, By Application, 2020 & 2028 (%)

Figure 30 South America Biopharmaceuticals Market Share, By Country, 2020 & 2028 (%)

Figure 31 Europe Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 32 Europe Biopharmaceuticals Market Share, By Type, 2020 & 2028 (%)

Figure 33 Europe Biopharmaceuticals Market Share, By Application, 2020 & 2028 (%)

Figure 34 Europe Biopharmaceuticals Market Share, By Country, 2020 & 2028 (%)

Figure 35 Asia-Pacific Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 36 Asia-Pacific Biopharmaceuticals Market Share, By Type, 2020 & 2028 (%)

Figure 37 Asia-Pacific Biopharmaceuticals Market Share, By Application, 2020 & 2028 (%)

Figure 38 Asia-Pacific Biopharmaceuticals Market Share, By Country, 2020 & 2028 (%)

Figure 39 Middle East & Africa Biopharmaceuticals Market Value, 2019-2028 ($ Million)

Figure 40 Middle East & Africa Biopharmaceuticals Market Share, By Type, 2020 & 2028 (%)

Figure 41 Middle East & Africa Biopharmaceuticals Market Share, By Application, 2020 & 2028 (%)

Figure 42 Abbvie Inc.: Financials

Figure 43 Amgen Inc.: Financials

Figure 44 Bristol-Myers Squibb Company: Financials

Figure 45 Eli Lilly and Company: Financials

Figure 46 Johnson & Johnson: Financials

Figure 47 Novartis AG: Financials

Figure 48 Novo Nordisk AS: Financials

Figure 49 Pfizer Inc.: Financials

Figure 50 GlaxoSmithKline PLC: Financials

Figure 51 F. Hoffmann-La Roche AG: Financials

Frequently Asked Questions

Q. At what CAGR is the Biopharmaceuticals market anticipated to augment?
A. The Biopharmaceuticals market is projected to strike 14.2% CAGR

Q. Who are the leading players in the Biopharmaceuticals market?
A. AbbVie Inc, Amgen, Bayer, Biogen, Bristol-Myers Squibb, ELI Lilly and Company, .Etc.

Q. What is the key driving factor of the Biopharmaceuticals market?
A. The major drivers fueling the growth of the market are an increase in the elderly population, the surge in prevalence of chronic diseases such as cancer and diabetes, increase in obesity and sedentary lifestyle among the population and growing acceptance for biopharmaceuticals

Overview

 

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest